Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
Top Cited Papers
Open Access
- 10 September 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 114 (11), 2273-2279
- https://doi.org/10.1182/blood-2009-03-212191
Abstract
BCL2 and MYC are oncogenes commonly deregulated in lymphomas. Concurrent BCL2 and MYC translocations (BCL2+/MYC+) were identified in 54 samples by kaKeywords
This publication has 51 references indexed in Scilit:
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasProceedings of the National Academy of Sciences of the United States of America, 2008
- Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledgeLeukemia, 2008
- Pax5: the guardian of B cell identity and functionNature Immunology, 2007
- Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomasLeukemia, 2007
- Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomesAnnals of Oncology, 2006
- Bcl2's Flexible Loop Domain Regulates p53 Binding and SurvivalMolecular and Cellular Biology, 2006
- Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)Blood, 2003
- Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B‐cell lymphomasBritish Journal of Haematology, 1999
- Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8; 14) translocation separate c-myc and the IgH locus up to several hundred kbHuman Molecular Genetics, 1992
- Activation of thec-mycOncogene in a Precursor-B-Cell Blast Crisis of Follicular Lymphoma, Presenting as Composite LymphomaThe New England Journal of Medicine, 1988